Thursday, June 27, 2024

LANGaware Forges Transformative Collaboration with Premier, Inc.’s PINC AI™ Applied Sciences (PAS) to Revolutionize Healthcare

Related stories

What Are AI APIs? Features, Types, and Working

The capacity of artificial intelligence (AI) to analyze massive...

CADDi Partners with PUNCH INDUSTRY USA to Solve Industry Challenges with CADDi Drawer Implementation

CADDi Drawer addresses time-intensive quoting and drawing management woes...

Bright Machines Raises $126M Series C Funding to Propel Manufacturing Into Software-Defined Era

Bright Machines, an innovator in intelligent, software-defined manufacturing, announced...

Sapient.ai Unveils Sapient Codeless: A Transformative Software Unit Testing Product

Sapient.ai, a leader in AI-driven software testing, introduced Sapient...
spot_imgspot_img

Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.

LANGaware, an innovative leader in digital cognitive and behavioral health diagnostics, is announcing that it will partner with Premier’s PINC AI™ Applied Sciences (PAS) to leverage Real-World Data (RWD) for the development of novel therapeutics addressing neurodegenerative and behavioral health diseases.

PAS, renowned for its robust data gleaned from over 4,350 hospitals and 300,000 continuum-of-care providers nationwide, will provide expertise in conducting prospective research utilizing retrospective synthetic arms built from the PINC AI™ Healthcare Database (PHD).

“Neurodegenerative diseases like Alzheimer’s and Parkinson’s and behavioral health conditions such as depression affect millions of people worldwide,” said Denise Juliano, Group Vice President of Life Sciences at PINC AI™ Applied Sciences. “The PAS-LANGaware partnership will enable RWD that supports early patient identification and detection – and drives evidence-based decisions by clinicians to improve quality, lower costs, reduce risk and help ensure safety for these patients.”

Also Read: Enhatch Announces FDA Clearance for a TKA Patient Specific Instrumentation System with AI-Assisted Segmentation and Treatment Planning

LANGaware, known for its AI-driven precision in early detection, aims to extend the availability of its platform to individuals, health systems and life science companies. Through unique voice and language biomarkers, LANGaware’s technology reduces the likelihood of false positives and unnecessary treatments.

“We are thrilled to partner with PAS and extend the reach of our digital assessment tool to more patients, health systems and life science companies,” said Vassiliki Rentoumi, Founder and CEO of LANGaware. “Our goal is to revolutionize early detection of cognitive and mental health diseases, supporting novel therapy development as well as earlier intervention by providers, to improve patient outcomes and drive positive changes in the healthcare industry. We are actively seeking partners that share our commitment to transforming patient care.”

The collaboration signifies a significant step forward in expanding access to advanced diagnostic services across the United States. By combining PAS’ extensive network of health systems and PINC AI’s RWD capabilities with LANGaware‘s cutting-edge technology, the partnership aims to revolutionize healthcare by driving innovation in early detection and treatment.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img